Home » Topics » Regulatory » Patents

Patents
RSS

Merck KGaA describes TGF-beta receptor inhibitors as oncolytics

Dec. 3, 2009

Glucocorticoid receptor modulators disclosed by Ligand as anti-inflammatory agents

Dec. 2, 2009

Novartis claims MMP inhibitors for the treatment of Alport syndrome

Dec. 2, 2009

Novel anxiolytic compounds identified by Forskarpatent

Dec. 2, 2009

Universidad de Oviedo describes oviedomycin derivatives for cancer therapy

Dec. 2, 2009

CB1 receptor antagonists described by sanofi-aventis for the treatment of obesity

Dec. 1, 2009

Novartis claims Toll-like receptor agonists for the treatment of asthma

Dec. 1, 2009

Novel compounds for the treatment of glaucoma claimed by Allergan

Dec. 1, 2009

Amira Pharmaceuticals describes CRTH2 antagonists for respiratory disorders

Dec. 1, 2009

Novel nAChR modulators in early development at NeuroSearch

Dec. 1, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...